Head-to-head · WeighScore
Nolu vs RX Bella
By GLP-1 ScorecardUpdated
Score comparison
Nolu has the higher recorded score — 69.7/100 to 67.8/100, but only just.
Nolu grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A wellness-branded compounded GLP-1 seller with an all-in per-order price and an oral semaglutide route — but its "$249" is billed per 4 weeks, not per calendar month. RX Bella is close behind and may still be the better fit — see the factor split below.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Nolu | RX Bella |
|---|---|---|
| WeighScore | 69.7/100 | 67.8/100 |
| Grade | C | C |
| Site position | #132 | #175 |
| Semaglutide | $249/mo injectable, $279/mo oral — billed per 4 weeks | From $249/mo (a floor, not a rate) |
| Tirzepatide | $339/mo — billed per 4 weeks | From $299/mo (a floor, not a rate) |
| Coverage | All 50 states plus Washington, D.C. | Nationwide telehealth, claimed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #132 · C
Strengths
- All-in per-order pricing — consultation, medication and shipping in one figure, no separate membership fee
- Oral semaglutide ($279 per 4 weeks) alongside the injectable, plus a Microdose GLP-1+B12/NAD+ stack ($179 per 4 weeks)
- LegitScript verified, available in all 50 states plus Washington, D.C.
What to consider
- Billed "per 4 weeks" rather than calendar month — roughly 8% higher annualized than the $249/$339 headline implies
- No named medical director, prescribers, or compounding pharmacy disclosed anywhere on the site
- Compounded only — not the FDA-approved brand product (Wegovy/Ozempic), which matters if you're relying on insurance
Site position #175 · C
Strengths
- All four programs — microdose, oral, semaglutide injection, tirzepatide injection — carry a figure on the homepage before any intake
- Nothing in the catalog is struck through: no invented "was" price and no expiring offer
- "$0 if you're not approved" is stated plainly and repeatedly
- The online provider visit, prescription, delivery and ongoing check-ins are stated as included
What to consider
- The hero's "from $199/mo" is the microdose; the tirzepatide program is $299
- Every figure is a floor, no dose ladder is published, and the eight-screen intake reaches an email gate without showing a price
- Its own treatment pages carry no dollar figure and read "AVAILABLE BY CONSULTATION"
- No lab or monitoring requirement is published
- The compounding pharmacies are never named and the footer names no company
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.